Laboratory test overuse occurs when tests are ordered repetitively, without due consideration of impact on clinical status. Repetitive inpatient lab testing often provides limited value for patient outcomes while increasing healthcare costs, patient discomfort, and unnecessary transfusions and prolonging hospitalizations. The research study aims to reduce laboratory test overuse in hospitals through implementation of a comprehensive, multi-disciplinary, and multi-faceted intervention bundle that includes audit and feedback reports, clinician education, clinical decision support tool, and patient infographics across 14 hospitals in Alberta.
Background: Laboratory and Pathology testing contributes to rising health care expenditure. A relatively large percentage (up to 42%) of laboratory testing can be considered wasteful. Redundant testing alone has been estimated to waste up to 5 billion dollars annually in the United States of America. Laboratory over-utilization leads to false positives that promotes further inappropriate testing and procedures, interruption of normal sleep pattern of inpatients, as well as iatrogenic anemia and pain. A Canadian study showed significant hemoglobin reductions as a result of phlebotomy. Studies support the safe reduction of repetitive laboratory testing without negative effects on adverse events, readmission rates, critical care utilization, or mortality. The aim of this research study is the following: 1. To implement a multimodal intervention bundle containing healthcare provider and patient engagement tools for hospitalized medical inpatients in 14 hospitals across the province of Alberta in Canada using a cluster randomized stepped-wedge design 2. To evaluate the impact of the intervention bundle on laboratory test utilization of six target laboratory tests (complete blood count, electrolytes, creatinine, urea, partial thromboplastin time, and international normalized ratio), costs, and patient safety outcomes. This intervention bundle will be implemented across all the adult hospital sites in Alberta starting January 2023 and evaluated until October 2024.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
251,817
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.
University of Calgary
Calgary, Alberta, Canada
Number of routine laboratory tests ordered per patient-day in the intervention versus control periods
Number of the six target laboratory tests (complete blood count, electrolytes, creatinine, urea, international normalized ratio and partial thromboplastin time) ordered per patient-day
Time frame: 1 year 9 months
Costs associated with routine and all common laboratory test ordered
Costs of test and associated costs with and without intervention
Time frame: 1 year 9 months
Proportion of hospital patient lab-free days
Number of hospital patient-days not associated with laboratory blood draws
Time frame: 1 year 9 months
Proportion of critically abnormal test results
As defined by lab standards, we will track the proportion of critically abnormal test results
Time frame: 1 year 9 months
Length of stay
Patient length of stay on the unit
Time frame: 1 year 9 months
Transfer to Intensive Care Unit
Transfer rate to Intensive Care Unit
Time frame: 1 year 9 months
In-patient and 30-day patient mortality over study period
Mortality rate in hospital and at 30-days post discharge
Time frame: 30 days post discharge
30-day post discharge readmission rate
Hospital re-admission within 30 days post discharge
Time frame: 30 days post discharge
Number of all common laboratory tests
Number of all common laboratory tests (tests that contribute to \>80% of hospital laboratory test utilization during study period) per patient-day.
Time frame: 1 year 9 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.